Chemodex

Trimethoprim sulfate

Product Code:
 
CDX-T0146
Product Group:
 
Inhibitors and Activators
Supplier:
 
Chemodex
Regulatory Status:
 
RUO
Shipping:
 
Ambient
Storage:
 
+4°C
1 / 1
Chemical Structure

Chemical Structure

No additional charges, what you see is what you pay! *

CodeSizePrice
CDX-T0146-M02525 mg£121.00
Quantity:
CDX-T0146-M100100 mg£340.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Switzerland.
Typical lead time: 7-10 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Alternate Names/Synonyms:
2,4-Pyrimidinediamine, 5-((3,4-trimethoxyphenyl)methyl)-, sulfate (2:1); BW 72U
Appearance:
White powder.
CAS:
56585-33-2
EClass:
32160000
Form (Short):
liquid
Handling Advice:
Keep cool and dry.Protect from light and moisture.
InChi:
InChI=1S/2C14H18N4O3.H2O4S/c2*1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15;1-5(2,3)4/h2*5-7H,4H2,1-3H3,(H4,15,16,17,18);(H2,1,2,3,4)
InChiKey:
UILMMYFRNCCPLK-UHFFFAOYSA-N
Long Description:
Chemical. CAS: 56585-33-2. Formula: C28H38N8O10S. MW: 678.24. Synthetic Antibacterial compound. Pyrimidine inhibitor of dihydrofolate reductase.
MDL:
MFCD28386658
Molecular Formula:
C28H38N8O10S
Molecular Weight:
678.24
Package Type:
Vial
Product Description:
Antibacterial compound. Pyrimidine inhibitor of dihydrofolate reductase.
Purity:
>99% (HPLC)
SMILES:
[O-]S([O-])(=O)=O.COC1=CC(CC2=CN=C([NH3+])N=C2N)=CC(OC)=C1OC.COC1=CC(CC2=CN=C(N)N=C2[NH3+])=CC(OC)=C1OC
Solubility Chemicals:
Soluble in water.
Source / Host:
Synthetic
Transportation:
Non-hazardous
UNSPSC Category:
Biochemical Reagents
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.

References

(1) M. Miovic & L.I. Pizer; J. Bacteriol. 106, 856 (1971) | (2) M. Poe; Science 194, 533 (1976) | (3) D.J. Baker, et al.; FEBS Lett. 126, 49 (1981) | (4) R. Gleckman, et al.; Pharmacotherapy 1, 14 (1981) | (5) P.C. Braga, et al.; J. Chemother. 5, 447 (1993)